Accurate calculation of the absolute free energy of binding for drug molecules; Two‐and three‐dimensional rings in drugs; Data-driven strategies for accelerated materials design; Nanoparticle synthesis assisted by machine learning; Large scale relative protein ligand binding affinities using non-equilibrium alchemy; Predictions of ligand selectivity from absolute binding free energy calculations; Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance; The Fragment molecular orbital method reveals new insight into the chemical nature of GPCR–ligand interactions; Statistical analysis on the performance of molecular mechanics poisson–boltzmann surface area versus absolute binding free energy calculations: Bromodomains as a case study; The SAMPL6 SAMPLing challenge: assessing the reliability and efficiency of binding free energy calculations; A molecular mechanism for transthyretin amyloidogenesis; Accurate estimation of ligand binding affinity changes upon protein mutation; Gryffin: An algorithm for Bayesian optimization of categorical variables informed by expert knowledge; Machine learning directed drug formulation development; On scientific understanding with artificial intelligence; Fragment molecular orbital method applied to lead optimization of novel interleukin-2 inducible T-cell kinase (ITK) inhibitors; Olympus: a benchmarking framework for noisy optimization and experiment planning; Large-scale analysis of water stability in bromodomain binding pockets with grand canonical Monte Carlo; Self‐driving platform for metal nanoparticle synthesis: combining microfluidics and machine learning; Accurate absolute free energies for ligand–protein binding based on non-equilibrium approaches
